398 related articles for article (PubMed ID: 30954920)
1. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells.
Bader S; Wolf L; Milenkovic VM; Gruber M; Nothdurfter C; Rupprecht R; Wetzel CH
Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920
[TBL] [Abstract][Full Text] [Related]
2. Translocator protein 18 kDa is involved in the regulation of reactive gliosis.
Veiga S; Carrero P; Pernia O; Azcoitia I; Garcia-Segura LM
Glia; 2007 Nov; 55(14):1426-36. PubMed ID: 17674368
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9 Mediated TSPO Gene Knockout alters Respiration and Cellular Metabolism in Human Primary Microglia Cells.
Milenkovic VM; Slim D; Bader S; Koch V; Heinl ES; Alvarez-Carbonell D; Nothdurfter C; Rupprecht R; Wetzel CH
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31323920
[TBL] [Abstract][Full Text] [Related]
4. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response.
Veenman L; Papadopoulos V; Gavish M
Curr Pharm Des; 2007; 13(23):2385-405. PubMed ID: 17692008
[TBL] [Abstract][Full Text] [Related]
5. Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis.
Karlstetter M; Nothdurfter C; Aslanidis A; Moeller K; Horn F; Scholz R; Neumann H; Weber BH; Rupprecht R; Langmann T
J Neuroinflammation; 2014 Jan; 11():3. PubMed ID: 24397957
[TBL] [Abstract][Full Text] [Related]
6. Translocator protein as a promising target for novel anxiolytics.
Costa B; Da Pozzo E; Martini C
Curr Top Med Chem; 2012; 12(4):270-85. PubMed ID: 22204481
[TBL] [Abstract][Full Text] [Related]
7. TSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis.
Lejri I; Grimm A; Hallé F; Abarghaz M; Klein C; Maitre M; Schmitt M; Bourguignon JJ; Mensah-Nyagan AG; Bihel F; Eckert A
J Alzheimers Dis; 2019; 72(4):1045-1058. PubMed ID: 31256132
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
Taliani S; Pugliesi I; Da Settimo F
Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
[TBL] [Abstract][Full Text] [Related]
9. The Ligands of Translocator Protein: Design and Biological Properties.
Mokrov GV; Deeva OA; Gudasheva TA
Curr Pharm Des; 2021; 27(2):217-237. PubMed ID: 32881658
[TBL] [Abstract][Full Text] [Related]
10. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression.
Veenman L; Gavish M
Curr Mol Med; 2012 May; 12(4):398-412. PubMed ID: 22348610
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria modulatory effects of new TSPO ligands in a cellular model of tauopathies.
Grimm A; Lejri I; Hallé F; Schmitt M; Götz J; Bihel F; Eckert A
J Neuroendocrinol; 2020 Jan; 32(1):e12796. PubMed ID: 31536662
[TBL] [Abstract][Full Text] [Related]
12. Targeting mitochondrial energy metabolism with TSPO ligands.
Gut P
Biochem Soc Trans; 2015 Aug; 43(4):537-42. PubMed ID: 26551690
[TBL] [Abstract][Full Text] [Related]
13. Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state.
Choi J; Ifuku M; Noda M; Guilarte TR
Glia; 2011 Feb; 59(2):219-30. PubMed ID: 21125642
[TBL] [Abstract][Full Text] [Related]
14. The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS.
Azrad M; Zeineh N; Weizman A; Veenman L; Gavish M
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704062
[TBL] [Abstract][Full Text] [Related]
15. Intracellular cholesterol changes induced by translocator protein (18 kDa) TSPO/PBR ligands.
Falchi AM; Battetta B; Sanna F; Piludu M; Sogos V; Serra M; Melis M; Putzolu M; Diaz G
Neuropharmacology; 2007 Aug; 53(2):318-29. PubMed ID: 17631921
[TBL] [Abstract][Full Text] [Related]
16. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
[TBL] [Abstract][Full Text] [Related]
17. Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines.
Wolf L; Bauer A; Melchner D; Hallof-Buestrich H; Stoertebecker P; Haen E; Kreutz M; Sarubin N; Milenkovic VM; Wetzel CH; Rupprecht R; Nothdurfter C
Pharmacopsychiatry; 2015 Mar; 48(2):72-7. PubMed ID: 25654303
[TBL] [Abstract][Full Text] [Related]
18. Targeting translocator protein (18 kDa) (TSPO) dampens pro-inflammatory microglia reactivity in the retina and protects from degeneration.
Scholz R; Caramoy A; Bhuckory MB; Rashid K; Chen M; Xu H; Grimm C; Langmann T
J Neuroinflammation; 2015 Nov; 12():201. PubMed ID: 26527153
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotection by the TSPO ligand 4'-chlorodiazepam is associated with inhibition of mitochondrial accumulation of cholesterol at reperfusion.
Paradis S; Leoni V; Caccia C; Berdeaux A; Morin D
Cardiovasc Res; 2013 Jun; 98(3):420-7. PubMed ID: 23554458
[TBL] [Abstract][Full Text] [Related]
20. Distribution, pharmacological characterization and function of the 18 kDa translocator protein in rat small intestine.
Ostuni MA; Péranzi G; Ducroc RA; Fasseu M; Vidic B; Dumont J; Papadopoulos V; Lacapere JJ
Biol Cell; 2009 Jul; 101(10):573-86. PubMed ID: 19392661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
